Posted on October 4, 2012
The Image Gently site contains a wealth of information including dose reduction techniques, latest research and educational materials for all imaging stakeholders
This entry was posted in General, News.
Awesome blog article.Thanks Again. Really Cool.
Im thankful for the post.Much thanks again. Awesome.
I really like and appreciate your blog post.Much thanks again.
structural engineers columbia sc
I truly appreciate this article post.Thanks Again. Will read on…
Affiliate Cash Craze Review
Thank you for your article. Great.
reparatii aer conditionat
Awesome blog article.Thanks Again. Keep writing.
annuaire federation sophrologie coaching
I really liked your blog post.Thanks Again. Fantastic.
Amusement Parks Hotels
Great blog post.Really looking forward to read more. Awesome.
website management Toronto
Very good blog. Want more.
best 7 inch tablet
Excellent details is usually located on this web blog.
My spouse and that i have been now delighted that Albert could execute his studies thanks to the ideas he had as a result of your online page. It can be every so often perplexing to just normally be freely giving techniques which a number of people cou…
This actually answered my drawback, thank you!
Novel MRI Technique Could Reduce Breast Biopsies
At A Glance
•Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies.
•Research has shown that diffusion-weighted imaging is a promising tool for distinguishing between benign and malignant breast lesions.
•Diffusion-weighted imaging successfully characterized 46 percent of non-malignant breast lesions identified as false-positive findings on DCE-MRI.
OAK BROOK, Ill. — Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.
Dynamic contrast-enhanced MRI (DCE-MRI) has emerged in recent years as a useful tool in breast cancer detection and staging. One of its primary limitations is a substantial number of false-positive findings that require biopsies.
“Many benign lesions demonstrate enhancement on DCE-MRI,” said Savannah C. Partridge, Ph.D., research associate professor at the University of Washington, Seattle Cancer Care Alliance. “We need another means for differentiating benign lesions from malignancies.”
One possible solution is diffusion-weighted imaging (DWI), an MRI technique that calculates the apparent diffusion coefficient (ADC)—a measure of how water moves through tissue.
“DWI has been used mostly in neurological applications, but it’s been studied more recently in breast imaging,” Dr. Partridge said. “It only adds a couple of minutes to the MRI exam and does not require additional contrast or any extra hardware.”
Research has shown that DWI is a promising tool for distinguishing between benign and malignant breast lesions. Normal breast tissue has a high ADC because water moves through it relatively freely, while most cancers have a lower ADC because their cells are more tightly packed and restrict water motion. However, significant overlap exists between the ADC values of non-malignant lesions and breast malignancies, and little is known about the ADC values of specific subtypes of non-malignant lesions.
For the new study, Dr. Partridge and colleagues evaluated the DWI characteristics of non-malignant lesions in 165 women. Based on ADC values above a previously determined diagnostic threshold, DWI successfully characterized 46 percent of non-malignant breast lesions identified as false-positive findings on DCE-MRI as benign.
“We were excited to see the number of false positives that could be reduced through this approach,” Dr. Partridge said. “DWI gives us extra microstructural information to distinguish among lesions. We can use ADC values to draw a cutoff above which we might not need to do a biopsy.”
The research team is planning a multicenter trial to validate the findings and determine how to best to incorporate ADC measures into clinical breast MRI interpretations.
“We are very motivated to translate this promising technology to a clinically useful breast imaging tool,” Dr. Partridge said.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account.
( Log Out /
You are commenting using your Google+ account.
( Log Out /
You are commenting using your Twitter account.
( Log Out /
You are commenting using your Facebook account.
( Log Out /
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.